top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Advancements in Cancer Theranostics : Integrating Imaging and Intervention / / edited by Rajendra Prasad, Murali Mohan Yallapu
Advancements in Cancer Theranostics : Integrating Imaging and Intervention / / edited by Rajendra Prasad, Murali Mohan Yallapu
Autore Prasad Rajendra
Edizione [1st ed. 2025.]
Pubbl/distr/stampa Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2025
Descrizione fisica 1 online resource (540 pages)
Disciplina 616.994
616.0754
Altri autori (Persone) Mohan YallapuMurali
Collana Biomedical and Life Sciences Series
Soggetto topico Cancer - Imaging
Cancer
Oncology
Nanomedicine
Drug delivery systems
Cancer Imaging
Cancer Biology
Cancer Nanotechnology
Drug Delivery
ISBN 981-9509-38-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Chapter 1. Conventional and modern theranostics approaches -- Chapter 2. Functional nanohybrids for solid tumor theranostics -- Chapter 3. Optical activatable photosensitizers for imaging and therapy -- Chapter 4. Next-generation multimode imaging and synergestic therapuetics for solid tumors -- Chapter 5. Molecular imaging and therapuetics approaches -- Chapter 6. Choice of nanomedicine in cancer imaging and therapuetics -- Chapter 7. Clinical validations of localized cancer nanomedicine -- Chapter 8. Nano-scavengers in near infrared light mediated photothermal cancer therapy -- Chapter 9. Progress in Magneto-Luminescent Nanomaterials for Cancer Theragnosis -- Chapter 10. Nanomaterial-based contrast and therapuetics agents -- Chapter 11. Cancer Imaging and Scope of early stage diagnosis: molecular imaging modalities -- Chapter 12. Functional biomedicine for image guided therapuetics of solid tumor -- Chapter 13. Multifacated nanoimaging agents and pre-clinical/clinical examinations for localized theranostics -- Chapter 14. Biosafety and Realibility of NanoImaging and Therapuetics -- Chapter 15. Cancer Imaging and Theranostics Intervention: Current Status and Future Perspective.
Record Nr. UNINA-9911031569203321
Prasad Rajendra  
Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2025
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Advances in Cancer Treatment : From Systemic Chemotherapy to Targeted Therapy / / by Iago Dillion Lima Cavalcanti, José Cleberson Santos Soares
Advances in Cancer Treatment : From Systemic Chemotherapy to Targeted Therapy / / by Iago Dillion Lima Cavalcanti, José Cleberson Santos Soares
Autore Cavalcanti Iago Dillion Lima
Edizione [1st ed. 2021.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Springer, , 2021
Descrizione fisica 1 online resource (VIII, 109 p. 27 illus., 25 illus. in color.)
Disciplina 616.994
Soggetto topico Oncology
Internal medicine
Pharmacy
Cancer—Treatment
Tumor markers
Cancer
Nanomedicine
Internal Medicine
Cancer Therapy
Tumour Biomarkers
Cancer Nanotechnology
Oncologia
Terapèutica
Fisiologia patològica
Nanomedicina
Soggetto genere / forma Llibres electrònics
ISBN 3-030-68334-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Introduction -- Cancer: concepts and epidemiology -- A brief history of cancer -- What is Cancer? -- Cancer Epidemiology -- Cancer development and immunology -- Cell cycle -- Cell cycle control: the function of cyclins -- Cancer triggering agents -- Proto-oncogenes -- Tumor suppressor genes -- Development of tumor mass -- Cancer Immunology -- Discovery of tumor markers -- Cancer diagnosis -- Impact of the discovery of tumor markers -- Main tumor markers for cancer diagnosis -- Alpha-fetoprotein (AFP) -- Human Chorionic Gonadotropin (β-HCG) -- Mucin-like cancer-associated antigen (MCA) -- CA 15.3 -- Carcinoembryonic antigen (CEA) -- Bladder tumor antigen (BTA) -- Telomerase -- Nuclear matrix protein (NMP 22) -- Cyfra 21.1 -- Prostatic acid phosphatase (PAP) -- Prostate-specific antigen (PSA) -- CA 125 -- CA 19.9 -- p53 -- CA 72.4 -- K-ras -- HER2 -- Cancer staging -- Conventional cancer treatment -- Therapeutic modalities of cancer -- Surgery -- Radiotherapy -- Antineoplastic chemotherapy -- Classification of antineoplastic agents by cycle -- Specific cycle antineoplastics -- Nonspecific antineoplastic agents -- Classification of antineoplastic agents by chemical structure and function -- Alkylating agents -- Antimetabolites -- Plant-derived antineoplastics -- Antitumor antibiotics -- Chemotherapy toxicity -- Hematological toxicity -- Liver toxicity -- Cardiac toxicity -- Anthracyclines -- Fluoropyrimidine -- Taxanes -- Pulmonary toxicity -- Neurological toxicity -- Renal toxicity -- Gastrointestinal toxicity -- Metabolic changes -- Targeted therapies in cancer treatment -- Overexpressed receptors on tumor cells -- Immunotherapy -- Monoclonal antibodies -- Types of monoclonal antibodies -- Side effects of monoclonal antibodies -- Checkpoint Inhibitors -- Side effects of checkpoint inhibitors -- Cancer Vaccines -- Vaccines in cancer prevention -- Vaccines for the treatment of cancer -- Non-specific immunotherapies -- Tyrosine kinase inhibitors -- Imatinib -- Gefitinib -- Erlotinib -- Sorafenib -- Dasatinib -- Nilotinib -- Lapatinib -- Adverse events of tyrosine kinase inhibitors -- Conventional chemotherapy vs. targeted therapy -- Differences between conventional chemotherapy and targeted therapy -- Risks and benefits of conventional chemotherapy compared to targeted therapy -- Eligibility criteria for the indication of the targeted therapy -- Side effects of targeted therapy -- Can targeted therapy replace conventional chemotherapy? -- Targeted therapy associated with conventional chemotherapy -- Pharmaceutical nanotechnology applied to cancer -- Pharmaceutical nanotechnology -- Classification of nanosystems -- Liposomes -- Micelles -- Polymeric nanoparticles -- Solid lipid nanoparticles -- Magnetic nanoparticles -- Metal nanoparticles -- Main functions of nanosystems in cancer -- Pharmaceutical nanotechnology in cancer diagnosis -- Pharmaceutical nanotechnology for cancer treatment.
Record Nr. UNINA-9910484989203321
Cavalcanti Iago Dillion Lima  
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Advances in Stimuli-Responsive Nanosystems for Cancer Therapy / / edited by Padma V. Devarajan, Sathish Dyawanapelly, Vijayabhaskarreddy Junnuthula
Advances in Stimuli-Responsive Nanosystems for Cancer Therapy / / edited by Padma V. Devarajan, Sathish Dyawanapelly, Vijayabhaskarreddy Junnuthula
Autore Devarajan Padma V
Edizione [1st ed. 2026.]
Pubbl/distr/stampa Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2026
Descrizione fisica 1 online resource (497 pages)
Disciplina 616.994
620.5
Altri autori (Persone) DyawanapellySathish
JunnuthulaVijayabhaskarreddy
Collana Biomedical and Life Sciences Series
Soggetto topico Cancer
Nanomedicine
Nanobiotechnology
Medicine - Research
Biology - Research
Materials
Bionics
Biomaterials
Cancer Nanotechnology
Biomedical Research
Cancer Biology
Bioinspired Materials
Biomedical Materials
ISBN 981-9527-44-9
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Chapter 1. Overview of Stimuli-Responsive Nanosystems: Endogenous and Exogenous Triggers for Stimuli-Responsive Delivery for Cancer Therapy -- Chapter 2. Stimuli-Responsive Micelles for Cancer Therapy -- Chapter 3. Stimuli-Responsive Polymeric Nanoparticles for Cancer Therapy -- Chapter 4. Stimuli-Responsive Polymersomes for Cancer Therapy -- Chapter 5. Stimuli-Responsive Dendrimers for Cancer Therapy -- Chapter 6. Stimuli-Responsive Liposomes for Cancer Therapy -- Chapter 7. Stimuli-Responsive Lipid Nanoparticle for Cancer Therapy -- Chapter 8. Stimuli-Responsive Mesoporous Silica Nanoparticles for Cancer Therapy -- Chapter 9. Stimuli-Responsive Nanogels for Cancer Therapy -- Chapter 10. Stimuli-Responsive Metal-Organic Frameworks for Cancer Therapy -- Chapter 11. Stimuli-Responsive Hydrogel for Cancer Therapy -- Chapter 12. Stimuli-Responsive Extracellular Vesicles / Exosomes -- Chapter 13. Dual and Multi-Stimuli Responsive Hydrogels for Cancer Therapy -- Chapter 14. Preclinical Studies on Stimuli-Responsive Nanosystems for Cancer Therapy.
Record Nr. UNINA-9911049070803321
Devarajan Padma V  
Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2026
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Biosensors and Aptamers : A New Era in Cancer Diagnosis and Treatment / / edited by Shriyansh Srivastava, Sachin Kumar, Sathvik Belagodu Sridhar, Malakapogu Ravindra Babu, Shaik Abdul Rahaman
Biosensors and Aptamers : A New Era in Cancer Diagnosis and Treatment / / edited by Shriyansh Srivastava, Sachin Kumar, Sathvik Belagodu Sridhar, Malakapogu Ravindra Babu, Shaik Abdul Rahaman
Autore Srivastava Shriyansh
Edizione [1st ed. 2025.]
Pubbl/distr/stampa Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2025
Descrizione fisica 1 online resource (497 pages)
Disciplina 616.994
620.5
Altri autori (Persone) KumarSachin
SridharSathvik Belagodu
Ravindra BabuMalakapogu
RahamanShaik Abdul
Soggetto topico Cancer
Nanomedicine
Oncology
Pharmacology
Pharmacy
Cancer Nanotechnology
ISBN 9789819683871
9789819683864
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto 1. Introduction to Biosensors and Aptamers: A New Era in Cancer Diagnosis and Treatment -- 2. The Biology of Cancer: Understanding the Disease and Its Challenges -- 3. Aptamers: A Novel Class of Targeted Therapeutics -- 4. Role of Biosensors in Transforming Cancer Diagnostics -- 5. Aptamer-Based Biosensors for Cancer Diagnosis -- 6. Targeted Cancer Therapy with Aptamers: A Review on the Current State -- 7. Aptamer-Based Cancer Diagnosis: Emerging updates -- 8. Designing Aptamers for Cancer Diagnosis and Therapy -- 9. Aptamer-Based Biosensors for Cancer Biomarker Detection -- 10. Aptamer-Based Biosensors for Cancer Imaging -- 11. Aptamer-Based Biosensors for Cancer Therapy Monitoring -- 12. Challenges and Limitations in Aptamer-Based Cancer Diagnosis and Therapy -- 13. Future Directions in Aptamer-Based Cancer Diagnosis and Therapy -- 14. Regulatory Frameworks and Intellectual property rights (IPR) for Aptamer-Based Cancer Diagnosis and Therapy.
Record Nr. UNINA-9911018761903321
Srivastava Shriyansh  
Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2025
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Biotechnology and Cancer Therapeutics / / edited by Manisha Nigam, Abhay Prakash Mishra
Biotechnology and Cancer Therapeutics / / edited by Manisha Nigam, Abhay Prakash Mishra
Edizione [1st ed. 2025.]
Pubbl/distr/stampa Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2025
Descrizione fisica 1 online resource (XVIII, 478 p. 41 illus.)
Disciplina 660.6
Collana Interdisciplinary Biotechnological Advances
Soggetto topico Biotechnology
Cancer
Therapeutics
Nanomedicine
Diagnosis
Cancer Biology
Cancer Nanotechnology
ISBN 981-9649-59-5
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto -- Chapter 1: Biotechnology in Medicine: Fundamentals -- Chapter 2: Molecular Diagnosis in Cancer -- Chapter 3: Cancer Immunotherapy -- Chapter 4: RNAi in Cancer Therapy - RNA Interference (RNAi): A Promising Frontier in Cancer Therapy - Mechanisms, Challenges, and Future Perspectives -- Chapter 5: Cell Therapy of Cancer -- Chapter 6: Personalized Cancer Therapy -- Chapter 7: Drug Resistance and Novel Targets for Cancer Therapy -- Chapter 8: Epigenetics: Applications in Cancer Therapeutics -- Chapter 9: Biomarkers of Cancer -- Chapter 10:Small molecules in targeted cancer therapy -- Chapter 11:Monoclonal Antibodies and Cancer -- Chapter 12:Role of MicroRNAs in Cancer -- Chapter 13:Gene therapy of cancer -- Chapter 14:Biotechnology in drug discovery and development for cancer.
Record Nr. UNINA-9911002546003321
Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2025
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cancer Biomarkers in Diagnosis and Therapeutics / / edited by Adeeb Shehzad
Cancer Biomarkers in Diagnosis and Therapeutics / / edited by Adeeb Shehzad
Edizione [1st ed. 2022.]
Pubbl/distr/stampa Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2022
Descrizione fisica 1 online resource (372 pages)
Disciplina 616.994075
Collana Biomedical and Life Sciences Series
Soggetto topico Tumor markers
Cancer
Cancer - Treatment
Nanomedicine
Tumour Biomarkers
Cancer Biology
Cancer Therapy
Cancer Nanotechnology
ISBN 981-16-5758-0
981-16-5759-9
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Chapter 1. Introduction to cancer biomarkers -- Chapter 2.Technologies for identification and validation of cancer biomarkers -- Chapter 3. BIOMARKERS FOR CANCER DRUG DEVELOPMENT -- Chapter 4. Clinical proteomics: diagnostics and prognostic markers of Cancer -- Chapter 5.Microbiome as cancer biomarkers -- Chapter 6. Predictive biomarkers for anticancer drugs -- Chapter 7. Biomarkers in Cancer Survival and Drug Resistance -- Chapter 8. Biomarkers in tumor recurrence and metastasis -- Chapter 9. Biomarkers for Cancer Immunotherapy -- Chapter 10. Role of Biomarkers in Personalized Medicine -- Chapter 11.Development of Novel Cancer Biomarkers for Diagnosis and Prognosis -- Chapter 12. Nanotechnology for Cancer Biomarkers.
Record Nr. UNINA-9910743224703321
Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cancer Immunology and Genetics: An Interdisciplinary Approach / / edited by Nima Rezaei
Cancer Immunology and Genetics: An Interdisciplinary Approach / / edited by Nima Rezaei
Autore Rezaei Nima
Edizione [1st ed. 2025.]
Pubbl/distr/stampa Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2025
Descrizione fisica 1 online resource (1222 pages)
Disciplina 571.978
616.994
Collana Interdisciplinary Cancer Research
Soggetto topico Cancer
Cancer - Treatment
Oncology
Immunotherapy
Tumors - Immunological aspects
Nanomedicine
Cancer Biology
Cancer Therapy
Tumour Immunology
Cancer Nanotechnology
ISBN 3-031-99374-8
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Thymic Stromal Lymphopoietin and Malignancies -- Immunogenic Cancer Cell Death -- Epigenetics in Cancer Biology -- Microenvironment of Normal Looking Tissues Adjacent to Cancer: Matters Arising -- The Paradoxical Role of Immune Response in Cancer Microenvironment -- T Cells and Their Roles in Tumor Microenvironments -- Role of Regulatory Immune Cells in Tumour Microenvironment (TME) -- Exploring the Metabolic Reprogramming of Immune Cells in Tumor Microenvironments -- Innate Lymphoid Cells in Cancer Immunobiology and Immunotherapy -- Tumor-Associated Macrophages and Their Role in Cancer Progression and Treatment Strategies -- Tumor-associated Macrophages in Colorectal Cancer -- Impact of Siglec-Sialic Acid Axis on the Cancer Immune Response -- Mechanisms on Telomere Maintenance in Cancer Cells -- Classification of SNPs, Tips from the Basic Knowledge to the Clinical Outcomes -- The Potential Role of HLA-G on Cancer -- Two Sides of the Same Coin: Genes Involvement in Neurodegeneration and Cancer -- MicroRNA: Exploring Their Multifaceted Role in Cancer -- Role of miRNAs in cancer: Main Therapeutic, Diagnostic, and Oncogenic Features -- LncRNA: Secret Regulators of Cancer Metabolism -- Structure and Function of The H19 Long Non-Coding RNA in Cancer -- Genome Editing: Current Approaches and the Road Ahead in Cancer Research and Therapeutics -- Targeting Epigenetic Readers Using Small Molecule Binders and PROTAC Degraders -- Pharmacogenomics of Cancer Chemotherapy: Transporter Polymorphisms and Drug Response -- Genetic Variants Associated with Morphine Treatment in Cancer.
Record Nr. UNINA-9911018746303321
Rezaei Nima  
Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2025
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cancer Metastasis, Management and Complications: An Interdisciplinary Approach / / edited by Nima Rezaei
Cancer Metastasis, Management and Complications: An Interdisciplinary Approach / / edited by Nima Rezaei
Edizione [1st ed. 2025.]
Pubbl/distr/stampa Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2025
Descrizione fisica 1 online resource (XIII, 650 p. 55 illus., 49 illus. in color.)
Disciplina 571.978
616.994
Collana Interdisciplinary Cancer Research
Soggetto topico Cancer
Cancer - Treatment
Oncology
Immunotherapy
Tumors - Immunological aspects
Nanomedicine
Cancer Biology
Cancer Therapy
Tumour Immunology
Cancer Nanotechnology
ISBN 3-031-93546-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Musculoskeletal malignancies with unexpected presentations -- Mechanism of Tumor Growth and Metastasis -- Intricate Synergy of Mechanical and Biochemical Cues in the Transmigration of Cancer Cells Across the Endothelium -- Treatment of the Oligometastatic Patient -- Epidemiology, Diagnosis, Management, and Prognosis of Spinal Metastasis: The State of Art -- The Effects of Angiotensin-Converting Enzyme Inhibitors on Metastasis-associated Myeloid Cells -- Multidisciplinary Management of Colorectal Liver Metastases -- Oral Cavity as a Remote Destination of Cancer Metastasis -- Metastasis and the Endocrine-Disrupting Compound Bisphenol A -- Physical Activity in Cancer Patients -- Palliative Care in Childhood Cancers -- Occupational Therapy Approaches to Cancer Rehabilitatıon from Childhood to Adulthood: Aim, Scope and Innovations -- Cancer-Related Lymphedema and Physiotherapy -- Tools for The Assessment of Skeletal Muscle Mass and Its Clinical Application in Cancer -- Physiotherapy and Rehabilitation in Gynecologic Cancers -- Pelvic Floor Physiotherapy and Its Research Development in the Continuum of Gynecological, Prostate, and Colorectal Cancer Care -- Innovative Approaches for Psychological Distress among Cancer Survivors: An Inter/Transdisciplinary Perspective -- New Trends in Integrative Cancer Care: The Role of Exercise, Music, and Education -- Cognitive Impairment in CNS Related Cancer Therapy: Focus on Immunotherapy -- Prevention of Breast Cancer-related Lymphedema -- Hepatotoxicity of Anti-Cancer Drugs -- Cardiovascular Toxicities of Cancer Treatment -- Management Update in Immunotherapy and Kidney Injury -- Use of Photobiomodulation for Prevention and Treatment of Oral Mucositis Secondary to Cancer Therapies -- Patient Insurance Status, The Affordable Care Act, and Cancer Care Outcomes in the United States.
Record Nr. UNINA-9911007475803321
Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2025
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cancer Nanotechnology / / edited by Ângela Maria Almeida de Sousa, Christiane Pienna Soares, Marlus Chorilli
Cancer Nanotechnology / / edited by Ângela Maria Almeida de Sousa, Christiane Pienna Soares, Marlus Chorilli
Edizione [1st ed. 2023.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023
Descrizione fisica 1 online resource (386 pages)
Disciplina 616.99406
Collana Biomedical and Life Sciences Series
Soggetto topico Cancer
Nanomedicine
Cancer - Treatment
Nanotechnology
Cancer Nanotechnology
Cancer Therapy
ISBN 3-031-17831-9
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Platform to improve proteomic evaluation to cancer therapy -- Epigenetics in cancer therapy -- Diagnosis of metastatic cancer -- Intervention of the microbiome for cancer therapy -- Lipid nanocarriers in cancer therapy -- Polymeric nanocarriers in cancer therapy -- Inorganic nanocarriers in cancer therapy -- Functionalization of nanostructures in cancer treatment -- Nano-fabrication technologies as cancer models -- Monoclonal antibodies in nanosystems as a strategy for cancer treatment -- Peptides and proteins in nanosystems as a strategy for cancer treatment -- Gene silencing for cancer therapy -- Nanotechnology to correct mitochondrial disorders in cancer diseases -- Chronobiology and nanotechnology to personalized cancer therapy -- Mannosylated nanovaccines in cancer immunotherapy -- Performance of anticancer DNA nanovaccines -- Anticancer messenger RNA nanovaccines -- Nanoparticles for imaging diagnostic techniques in cancer -- Nanomaterials for cancer phototheragnostic -- Photoimmunological therapies for cancer -- Microneedle-based delivery devices for cancer therapy -- Clinical trials involving nanocarriers in cancer therapy.
Record Nr. UNINA-9910635395003321
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cancer Nanotheranostics : Volume 2 / / edited by Muthupandian Saravanan, Hamed Barabadi
Cancer Nanotheranostics : Volume 2 / / edited by Muthupandian Saravanan, Hamed Barabadi
Autore Saravanan Muthupandian
Edizione [1st ed. 2021.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Springer, , 2021
Descrizione fisica 1 online resource (379 pages) : illustrations
Disciplina 616.9940072
Collana Nanotechnology in the Life Sciences
Soggetto topico Cancer
Nanomedicine
Nanobiotechnology
Cancer Nanotechnology
Cancer Biology
Càncer
Soggetto genere / forma Llibres electrònics
ISBN 3-030-76263-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Preface -- Nanotheranostics -- Multifunctional Nanoparticles for Targeting Cancer Nanotheranostics -- Nano-Oncology -- Cancer-Targeted Nanotheranostics -- Nanotheranostics -- Cancer Nano-Immunotherapy -- Recent Advances in Lipid-Based Nanoformulations for Breast Cancer Theranostics -- Nanoparticle for Photoresponsive Minimal-Invasive Cancer Therapy -- Biologically Synthesized Plant-Derived Nanomedicines and their In-Vitro In-Vivo Toxicity Studies in Various Cancer Therapeutics -- Nanoerythrosome -- Role of Artificial Intelligence in Cancer Nanotheranostics -- Limitations of Current Cancer Nanotheranositcs -- Safety of nanobiomaterials for Cancer Nanotheranostics -- Index.
Record Nr. UNINA-9910502646403321
Saravanan Muthupandian  
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui